Prescription Lab Compounding Pharmacy
FDA inspection history across 2 sites, 2015 to 2017
- 2
- Warning letters
- 1
- Close-out
- 1
- Form 483
Every document, by year
- Close-out
- Warning letter
- Form 483
2015: one Form 483; 2016: one warning letter; 2017: one close-out letter and one warning letter.
The story so far
Built from the dates and citations on the documents themselves.
- 2015–17Two warning letters, one Form 483 and one close-out letter, at Tucs on, Arizona and Tucson, Arizona.
Cited most
Across all Prescription Lab Compounding Pharmacy observations on file
- 21 CFR 211.42Design and construction features2
- 21 CFR 211.113Control of microbiological contamination1
- 21 CFR 211.166Stability testing1
The complete Prescription Lab Compounding Pharmacy file.
All 4 documents as original PDFs, in one order. For supplier audits, diligence and inspection prep.
The price of the documents, added to your cart together
Sites
Tucson, Arizona
Two warning letters and one close-out letter · 2016 to 2017
Latest: Close-out, Jun 27, 2017 →Tucs on, Arizona
One Form 483 · 2015 · 4 observations
Latest: Form 483, Sep 10, 2015 →
Documents
4 on file, newest first| Date | Document | Location | Observations | Price |
|---|---|---|---|---|
| 2017-06-27 | Close-out Close-out letter | Tucson, Arizona | — | $99 |
| 2017-05-23 | Warning letter Warning letter | Tucson, Arizona | — | $99 |
| 2016-11-16 | Warning letter Warning letter | Tucson, Arizona | — | $99 |
| 2015-09-10 | 483 Form 483 | Tucs on, Arizona | 4 | $99 |
Investigators on these documents
FEI number 3004578527 · most recent document Jun 27, 2017
About Prescription Lab Compounding Pharmacy
How many FDA Form 483s has Prescription Lab Compounding Pharmacy received?
FDA Intel has 1 Form 483 on file for Prescription Lab Compounding Pharmacy; the most recent is dated Sep 10, 2015.
When was Prescription Lab Compounding Pharmacy last inspected by FDA?
The most recent FDA inspection document on file for Prescription Lab Compounding Pharmacy is a Form 483 dated Sep 10, 2015, for the site in Tucs on, Arizona.
What did FDA cite at Prescription Lab Compounding Pharmacy?
The regulations cited most in the observations on file for Prescription Lab Compounding Pharmacy are 21 CFR 211.42 (Design and construction features), 2 times; 21 CFR 211.113 (Control of microbiological contamination), 1 time; 21 CFR 211.166 (Stability testing), 1 time.
Has Prescription Lab Compounding Pharmacy received an FDA warning letter?
Yes. FDA Intel has 2 FDA warning letters on file for Prescription Lab Compounding Pharmacy; the most recent is dated May 23, 2017.